WallStreetZenWallStreetZen

NASDAQ: AIMD
Ainos Inc Stock

$0.80+0.01 (+1.27%)
Updated Feb 3, 2023
AIMD Price
$0.80
Fair Value Price
$0.96
Market Cap
$16.01M
52 Week Low
$0.55
52 Week High
$18.00
P/E
-0.99x
P/B
0.44x
P/S
11.53x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.51M
Earnings
-$13.32M
Gross Margin
38.4%
Operating Margin
-528.96%
Profit Margin
-531.1%
Debt to Equity
0.07
Operating Cash Flow
-$3M
Beta
20.56
Next Earnings
Mar 1, 2023
Ex-Dividend
N/A
Next Dividend
N/A

AIMD Overview

Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AIMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AIMD ($0.80) is undervalued by 16.49% relative to our estimate of its Fair Value price of $0.96 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
AIMD ($0.80) is not significantly undervalued (16.49%) relative to our estimate of its Fair Value price of $0.96 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
AIMD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more AIMD due diligence checks available for Premium users.

Be the first to know about important AIMD news, forecast changes, insider trades & much more!

AIMD News

Valuation

AIMD fair value

Fair Value of AIMD stock based on Discounted Cash Flow (DCF)
Price
$0.80
Fair Value
$0.96
Undervalued by
16.49%
AIMD ($0.80) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AIMD ($0.80) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AIMD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

AIMD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.99x
Industry
10.7x
Market
15.09x

AIMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.44x
Industry
5.11x
AIMD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AIMD's financial health

Profit margin

Revenue
$1.8M
Net Income
-$7.8M
Profit Margin
-445%
AIMD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AIMD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$39.1M
Liabilities
$2.7M
Debt to equity
0.07
AIMD's short-term assets ($3.67M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AIMD's short-term assets ($3.67M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AIMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AIMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$786.6k
Investing
-$240.5k
Financing
$1.6M
AIMD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AIMD vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
AIMD$16.01M+1.27%-0.99x0.44x
PCSA$15.99M0.00%-0.91x0.93x
NNVC$16.14M-0.71%-2.24x0.75x
APM$15.78M-0.45%-1.52x0.70x
LABP$16.50M-6.82%-0.30x0.37x

Ainos Stock FAQ

What is Ainos's quote symbol?

NASDAQ: AIMD) Ainos trades on the NASDAQ under the ticker symbol AIMD. Ainos stock quotes can also be displayed as NASDAQ: AIMD.

If you're new to stock investing, here's how to buy Ainos stock.

What is the 52 week high and low for Ainos (NASDAQ: AIMD)?

(NASDAQ: AIMD) Ainos's 52-week high was $18.00, and its 52-week low was $0.55. It is currently -95.56% from its 52-week high and 44.4% from its 52-week low.

How much is Ainos stock worth today?

(NASDAQ: AIMD) Ainos currently has 20,011,602 outstanding shares. With Ainos stock trading at $0.80 per share, the total value of Ainos stock (market capitalization) is $16.01M.

Ainos stock was originally listed at a price of $0.18 in Jan 19, 2021. If you had invested in Ainos stock at $0.18, your return over the last 2 years would have been 334.78%, for an annualized return of 108.51% (not including any dividends or dividend reinvestments).

How much is Ainos's stock price per share?

(NASDAQ: AIMD) Ainos stock price per share is $0.80 today (as of Feb 3, 2023).

What is Ainos's Market Cap?

(NASDAQ: AIMD) Ainos's market cap is $16.01M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ainos's market cap is calculated by multiplying AIMD's current stock price of $0.80 by AIMD's total outstanding shares of 20,011,602.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.